Oncology

Improving Knowledge and Overcoming Barriers to Optimal Therapy in Metastatic Renal Cell Carcinoma

The two main objectives of this initiative are to:

• Increase physician adherence to National Comprehensive Cancer Network (NCCN), dosing recommendations for metastatic renal cell carcinoma patients treated in the community
• As optimal dosing can significantly impact patient outcomes, oncologists and urologists’ lack of knowledge regarding recommended guidelines on dosing may reduce treatment efficacy
• Introduction of newer, more efficacious and well-tolerated therapies will enable community oncologists to manage various cancer patient at the local level, thereby decreasing the number of unnecessary referrals

• Improve access and visibility of clinical trials for metastatic renal cell carcinoma patients in the community
• As advancements in oncology research continue to unfold, the role of clinical trials will remain a significant part of patient management
• Lack of awareness by clinicians regarding available clinical trial enrollment opportunities may limit patients’ access to all available treatment options